Sciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the treatment of premature ejaculation (PE) in Europe. The study (more…)
Their gentle nature, large size, odd sounds and low-maintenance care have made Madagascar hissing cockroaches popular educational tools and pets for years. But the giant insects also have one unfortunate characteristic: Their hard bodies and feces are home to many mold species that could be triggering allergies in the kids and adults who handle the bugs, according to a new study.
Researchers have (more…)
Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, today announced the final analysis of its European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation (’PE’). (more…)
Powered by WordPress